Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide

Infection and Immunity

Volumn 64, Issue 1, 1996, Pages 69-76

  Kaplan, S S ^a,b   Lancaster Jr , J R ^a,c   Basford, R E ^a   Simmons, R L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SUPEROXIDE;

ARTICLE; BACTERICIDAL ACTIVITY; DOSE TIME EFFECT RELATION; HOST RESISTANCE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION;

EID: 0030052434     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.1.69-76.1996     Document Type: Article

References (62)

1. Babior, B. M., R. S. Kipnes, and J. T. Curnutte. 1973. Biological defense mechanisms The production by leukocytes of Superoxide, a potential bactericidal agent. J. Clin. Invest. 52:741.
2. Bastian, N. R., and J. B. Hibbs, Jr. 1994. Assembly and regulation of NADPH oxidase and nitric oxide synthase Curr. Opin. Immunol 6:131-139
3. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl. Acad. Sci USA 87:1620-1624
4. Beckman, J. S., and J. P. Crow. 1993 Pathological implications of nitric oxide, superoxide and peroxynitrite formation Biochem. Soc Trans. 21: 330-334
5. Belenky, S. N., R. A. Robbing, S. I. Rennard, G. L. Gossman, K. J. Nelson. and I. Rubinstein. 1993 Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro J. Lab Gin. Med. 122:388-394.
6. Belenky, S. N., R. A. Robbins, and I. Rubinstein. 1993. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J. Leuk. Biol. 533: 498-503.
7. GN-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J. Leuk. Biol. 48:565-569.
8. Cameron, M. L., D. L. Granger, J. B. Weinberg, W. S. Lozumbo, and H. S. Karen. 1990 Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev. Respir. Dis. 142:1313-1319.
9. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122
10. Clancy, R. M., J. Leszczynska-Piziak, and S. B. Abramson. 1992 Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase J. Clin. Invest. 90:1116-1121.
11. Croen, K. D. 1993. Evidence for an antiviral effect of nitric oxide Inhibition of herpes simplex virus type 1 replication. J Clin Invest. 91:2446-2452.
12. Denis, M. 1991. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leuk. Biol 49:380-387.
13. Dumarey, C. H., V. Labrousse, N. Rastogi, B. B. Vargaftig, and M. Bachelet, 1994. Selective mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J Leuk. Biol. 56:36-40
14. Fukahori, M., K. Ichimori, H. Ishida, H. Nakagawa, and H. Okino. 1994. Nitric oxide reversibly suppresses xanthine oxidase activity. Free Radical Res. 21:203-212
15. Garthwaite, J. 1991. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14:60-67.
16. Gladstone, G. P., and E. Walton. 1971. The effect of iron and hematin on the killing of staphylococci by rabbit polymorphs. Br. J. Exp Pathol. 52:452.
17. Goode, H. F., N. R. Webster, P. D. Howdle, and B. E. Walker. 1994 Nitric oxide production by human peripheral blood polymorphonuclear leukocytes. Clin Sci. 86:411-415.
18. 15N) nitrate in biological fluids. Anal. Biochem 126:131-138.
19. Hasan, K., J. B. Heesen, J. A. Corbett, M. L. McDaniel, K. Chang, W. Allison, B. H. R. Wolffenbuttel, J. R. Williamsoa, and R. G. Tilton. 1993. Inhibition of nitric oxide formation by guanidmes. Eur. J Pharmacol 249: 101-106.
20. Hibbs, J. B., Jr., J. L. Granger, J. L. Krahenbuhl, and L. B. Adams. 1992. Synthesis of nitric oxide from L-argmme. a cytokine inducible pathway with antimicrobial activity, p. 279-292 In R. van Furth (ed.), Mononuclear phagocytes: biology of monocytes and macrophages. Kluwer Academic Publishers. Dordrecht, The Netherlands.
21. Hibbs, J. B., Jr., R. R. Taintor, Z. Vavrin, D. L. Granger, J.-C. Drapier, I. J. Amber, and J. R. Lancaster, Jr. 1990. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. p. 189-223. In S Moncada and E A. Higgs (ed.), Nitric oxide from L-arginine: a bioregulatory system Elsevier, New York.
22. Hibbs, J. B., Jr., R. R. Taintor, Z. Vavrin, and E. M. Rochlin. 1988. Nitric oxide a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res Commun. 157:87-94
23. Hoffman, R. A., J. M. Langrehr, T. R. Billiar, R. D. Curran, and R. L. Simmons. 1990. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol. 145:2220-2226.
24. Huie, R. E., and S. Padmaja. 1993. The reaction of NO with superoxide Free Radical Res Commun. 18:195-199.
25. Ignarro, L. J., D. Y. Bany, D. Y. Crueller, J. C. Edward, and E. O. Ohlsterin. 1980 Guanylate cyclase activity by nitroprusside and nitrosoguanidine is related to the formation of S-nitrosothiol intermediates. Biochem. Biophys. Res Commun 94:93-100.
26. Ischiropoulos, H., L. Zhu, and J. S. Beckman. 1992 Peroxynitrite formation from macrophage-derived nitric oxide Arch Biochem. Biophys. 298:446-451
27. James, S. L., R. W. Cook, and J. K. Lazdins. 1990. Activation of human monocyte-derived macrophages to kill schistosomula of Schistosoma mansom in vitro. J Immunol. 145:2686-2690.
28. G-monomethyl-L-arginine: a role for cyclic GMP Blood 74:1885-1887.
29. Kilbourn, R. G., S. S. Gross, A. Jubran, et al. 1990. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension, implications for the involvement of nitric oxide. Proc Natl Acad. Sci. USA 87:3629-3632
30. Koppenol, W. H., J. J. Moreno, W. A. Pryor, H. Ischiropoulos, and J. S. Beckman. 1992 Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol. 5:834-842.
31. 30a Kuhns, D. B., et al. Personal communication.
32. Lancaster, J. R., Jr. 1994. Simulation of the diffusion and reaction of endo genously produced nitric oxide. Proc. Natl. Acad Sci. USA 91:8137-8141.
33. Lancaster, J. R., Jr., and J. B. Hibbs, Jr. 1990. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc. Natl. Acad Sci. USA 87:1223-1227.
34. Liew, F. Y., S. Millott, C. Parkinson, R. M. J. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-argimne. J. Immunol. 144:4794-4-797.
35. Malawista, S. E., R. R. Montgomery, and G. Van Blaricom. 1992. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts - a new microbiocidal pathway for polymorphonuclear leukocytes. J. Clin. Invest. 90:631-636.
36. Mitrovic, B., L. J. Ignarro, S. Montestruque, A. Smoll, and J. E. Merrill. 1994 Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro Neurosciencc 61:575-585.
37. Moilanen, E. P., P. Vuorinen, H. Kankaanranta, T. Metsa-Ketela, and H. Vapaatalo. 1993 Inhibition by nitric oxide-donors of human polymorphonuclear leukocyte functions. Br. J. Pharmacol. 109:852-858.
38. Munoz-Fernandez, M. A., M. A. Fernandez, and M. Fresno. 1992. Activation of human macrophages for the killing of intracellular Trypansoma cruzi by TNF-α and IFN-γ through a nitric oxide dependent mechanism. Immunol. Lett. 33:35-40
39. Murray, H. W., and R. F. Titelbaum. 1992. L-arginme-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis 165:513-517
40. Nathan, C. 1992. Nitric oxide as A secretory product of mammalian cells. FASEB J. 6:3051-3064.
41. Newberger, P. E., M. E. Chovaniac, and H. J. Cohen. 1980. Activity and activation of the granulocyte superoxide generating system. Blood 55:85-92.
42. Nussler, A. K., M. DiSilvio, T. R. Billiar, et al. 1992 Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin J. Exp. Med. 176:261-264.
43. Nussler, A. K., J. C. Drapier, L. Renia, S. Pied, F. Miltgen, M. Gentilini, and D. Mazier. 1991 L-Alinine dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin stimulation. Eur. J Immunol. 22:227-230.
44. O'Brien, L., J. Carmichael, D. B. Lowrie, and P. W. Andrew. 1994 Strains of mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect. Immun. 62:5187-5190.
45. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. Jones. 1994. NO as an effector molecule of parasite killing, modulation of its synthesis by cytokines Comp. Biochem Physiol. C Pharmacol. Toxicol. Endocrinol. 108:11-18
46. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biologic activity of endothelium derived relaxing factor Nature (London) 327:524-526
47. Reiling, N., A. J. Ulmer, M. Duchrow, M. Ernst, H.-D. Flad, and S. Hauschildt. 1994. Nitric oxide synthase. mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol. 24:1941-1944
48. Rockett, K. A., M. M. Auburn, W. B. Cowden, and I. A. Clark. 1991 Killing of Plasmodium falciparium in vitro by nitric oxide derivatives. Infect Immun 59:3280-3283.
49. 2 and to L-argimne-dependent systems in murine macrophages. Microbiol Immunol 35:325-329
50. Salvemini, U., G. DeNucci, R. J. Gryglewski, and J. R. Vane. 1989. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor Proc. Natl Acad. Sci. USA 86:6328-6332.
51. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Scaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis 167:1358-1363
52. Shank, J. K., H. Silliker, and R. H. Harper. 1962. The effect of nitric oxide on bacteria. Appl Microbiol. 10:185-189.
53. Stewart, A. G., G. J. Dusting, R. G. Giarracca, T. Harris, Y. Lim, and C. G. Sobey. 1993 Nitrite is produced by elicited but not circulating neutrophils. Mediat. Inflamm 2:349-356.
54. Stuehr, D. J., H. J. Cho, N. S. Kwon, M. F. Weise, and C. F. Nathan. 1991. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase. an FAD- and FMN-containing flavoprotein Proc. Natl. Acad. Sci. USA 88:7773-7777.
55. Tamir, S., R. S. Lewis, T. deRojas Walker, W. M. Deen, J. S. Wishnok, and S. R. Tannenbaum. 1993. The influence of delivery rate on the chemistry and biological effects of nitric oxide. Chem. Res. Toxicol. 6:895-899.
56. Tarr, H. L. A. 1941. Bacteriostatic action of nitrates. Nature (London) 147: 417-418.
57. Weinbaum, D. L., S. S. Kaplan, U. E. Zdziarski, C. R. Rinaldo, Jr., and K. K. Schroeder. 1984. Human polymorphonuclear leukocyte interaction with cylosporine A. Infect. Immun. 43:791-794
58. Wiedermann, C. J., B. Sitte, U. Zilian, N. Reinisch, H. Beimpold, G. Finkenstedt, and H. Braunsteiner. 1993. Inhibition of superoxide anion release from circulating neutrophils by L-argmine in man Clin. Invest. 71:985-989.
59. Wink, D. A., I. Hanbauer, M. C. Krishna, W. DeGraff, J. Gamson, and J. B. Mitchell. 1993. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA 90:9813-9817.
60. Wood, J., and J. Garthwaite. 1994. Models for the diffusional spread of nitric oxide: implications for neuronal nitric oxide signalling and its pharmacological properties. Neuropharmacology 33:1235-1244.
61. Yan, L., R. W. Vandivier, A. F. Suffredini, and R. L. Danner. 1994. Human polymorphonuclear leukocytes lack detectable nitric oxide symthase activity. J. Immunol. 153:1825.
62. Zembala, M., M. Siedlar, J. Marcinkiewicz, and J. Pryjma. 1994. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur. J. Immunol 24:435-439.